Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Dissemination of health technologies: Trends in the use of diagnostic test in breast cancer screening.

Natal C, Fernandez-Somoano A, Torá-Rocamora I, Vidal C, Castells X, Tardón A; Benign Lesion Study Group; Benign Lesion Study Group.

J Healthc Qual Res. 2019 Jul - Aug;34(4):177-184. doi: 10.1016/j.jhqr.2019.02.007. Epub 2019 Jun 28.

PMID:
31713528
2.

[Influence of diagnostic pathway on clinical and non-conventional therapies use in women with breast cancer of the cohort DAMA].

Torá-Rocamora I, Grau J, Oliver-Vall-Llosera B, Bargalló X, Aldea M, Puigpinós-Riera R; grupo Cohorte DAMA.

Gac Sanit. 2019 Apr 15. pii: S0213-9111(19)30078-0. doi: 10.1016/j.gaceta.2019.02.006. [Epub ahead of print] Spanish.

3.

Impact of a Primary Care intervention on the colorectal cancer early detection programme.

Luque Mellado FJ, Paino Pardal L, Condomines Feliu I, Tora-Rocamora I, Cuadras Rofastes M, Romero Díaz E, Pacheco Ortiz M, Camuñez Bravo JC, Aldea M, Grau Cano J; grupo de investigación PROCOLON.

Gastroenterol Hepatol. 2019 Jun - Jul;42(6):351-361. doi: 10.1016/j.gastrohep.2019.01.007. Epub 2019 Apr 4. English, Spanish.

PMID:
30954319
4.

Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program.

Buron A, Román M, Augé JM, Macià F, Grau J, Sala M, Louro J, Martinez-Alonso M, Alvarez-Urturi C, Andreu M, Bessa X, Zaffalon D, Castells A, Pellisé M, Aldea M, Rivero L, Hernández C, Torá-Rocamora I, Castells X.

Eur J Cancer. 2019 Jan;107:53-59. doi: 10.1016/j.ejca.2018.11.004. Epub 2018 Dec 10.

PMID:
30544059
5.

Survival and Disease-Free Survival by Breast Density and Phenotype in Interval Breast Cancers.

Sala M, Domingo L, Louro J, Torá-Rocamora I, Baré M, Ferrer J, Carmona-Garcia MC, Barata T, Román M, Macià F, Castells X; CAMISS Study Group.

Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):908-916. doi: 10.1158/1055-9965.EPI-17-0995. Epub 2018 May 31.

6.

Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain.

Román M, Caicoya M, Espinàs J, Sala M, Torá-Rocamora I, Quinta MJ, Vernet M, Saladié F, Romero A, Sánchez M, Baré M, Vidal C, Servitja S, Natal C, Corominas J, Ferrer J, Rodríguez-Arana A, Castells X; BELE Project study group.

Breast J. 2018 Jul;24(4):509-518. doi: 10.1111/tbj.13003. Epub 2018 Mar 8.

PMID:
29517151
7.

Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study.

Posso M, Corominas JM, Serrano L, Román M, Torá-Rocamora I, Domingo L, Romero A, Quintana MJ, Vernet-Tomas M, Baré M, Vidal C, Sánchez M, Saladié F, Natal C, Ferrer J, Servitja S, Sala M, Castells X; BELE Study Group.

Cancer Med. 2017 Jun;6(6):1482-1489. doi: 10.1002/cam4.1080. Epub 2017 May 4.

8.

Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs.

Romero A, Torà-Rocamora I, Baré M, Barata T, Domingo L, Ferrer J, Torà N, Comas M, Merenciano C, Macià F, Castells X, Sala M; CAMISS Study Group.

BMC Cancer. 2016 Sep 15;16(1):735. doi: 10.1186/s12885-016-2768-1.

9.

Gender differences in the duration of non-work-related sickness absence episodes due to musculoskeletal disorders.

Arcas MM, Delclos GL, Torá-Rocamora I, Martínez JM, Benavides FG.

J Epidemiol Community Health. 2016 Nov;70(11):1065-1073. doi: 10.1136/jech-2014-204331. Epub 2016 May 13.

PMID:
27177580
10.

[Variations in the diagnostic confirmation process between breast cancer mass screening units].

Natal C, Fernández-Somoano A, Torá-Rocamora I, Tardón A, Castells X; en nombre del grupo BELE.

Gac Sanit. 2016 Jul-Aug;30(4):265-71. doi: 10.1016/j.gaceta.2016.03.005. Epub 2016 Apr 29. Spanish.

11.

Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.

Castells X, Torá-Rocamora I, Posso M, Román M, Vernet-Tomas M, Rodríguez-Arana A, Domingo L, Vidal C, Baré M, Ferrer J, Quintana MJ, Sánchez M, Natal C, Espinàs JA, Saladié F, Sala M; BELE Study Group.

Radiology. 2016 Aug;280(2):379-86. doi: 10.1148/radiol.2016151174. Epub 2016 Feb 15.

PMID:
26878225
12.

Assessment of the magnitude of geographical variations in the duration of non-work-related sickness absence by individual and contextual factors.

Torá-Rocamora I, Martínez JM, Gimeno D, Alberti C, Jardí J, Manzanera R, Benavides FG, Delclos G.

Gac Sanit. 2015 May-Jun;29(3):164-71. doi: 10.1016/j.gaceta.2014.12.004. Epub 2015 Jan 28.

13.

Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.

Castells X, Domingo L, Corominas JM, Torá-Rocamora I, Quintana MJ, Baré M, Vidal C, Natal C, Sánchez M, Saladié F, Ferrer J, Vernet M, Servitja S, Rodríguez-Arana A, Roman M, Espinàs JA, Sala M.

Breast Cancer Res Treat. 2015 Jan;149(1):237-44. doi: 10.1007/s10549-014-3208-z. Epub 2014 Dec 13.

14.

Heterogeneity and event dependence in the analysis of sickness absence.

Torá-Rocamora I, Gimeno D, Delclos G, Benavides FG, Manzanera R, Jardí J, Alberti C, Yasui Y, Martínez JM.

BMC Med Res Methodol. 2013 Sep 16;13:114. doi: 10.1186/1471-2288-13-114.

15.

Occupational health impact of the 2009 H1N1 flu pandemic: surveillance of sickness absence.

Torá-Rocamora I, Delclos GL, Martínez JM, Jardí J, Alberti C, Manzanera R, Yasui Y, Clèries R, Tobías A, Benavides FG.

Occup Environ Med. 2012 Mar;69(3):205-10. doi: 10.1136/oem.2011.065003. Epub 2011 Jun 14.

PMID:
21676949
16.

[Duration of work absence attributable to non work-related diseases by health regions in catalonia].

Torá Rocamora I, Martínez Martínez JM, Delclos Clanchet J, Jardí Lliberia J, Alberti Casas C, Serra Pujadas C, Manzanera López R, Benavides FG.

Rev Esp Salud Publica. 2010 Jan-Feb;84(1):61-9. Spanish.

Supplemental Content

Loading ...
Support Center